Full name
SYMBIOPHARM LABORATORIES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
70.10.Z - Activities of head office and holding companies, excluding financial holding companies
2021 | 2022 | ||
---|---|---|---|
M PLN | M PLN | % | |
Assets | 0,5 | 1,2 | 148,6 |
Profit (loss) on sale | -0 | -0 | 37,9 |
Gross profit (loss) | 0,5 | 0,7 | 50,9 |
Net profit (loss) | 0,5 | 0,7 | 50,9 |
Cash | 0 | 0 | -22,4 |
Net income from sale | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 0 | 0,4 | 16 524,5 |
Short time liabilities | 0 | 0,4 | 16 524,5 |
Equity capital | 0,5 | 0,8 | 71,1 |
Working assets | 0,5 | 1,2 | 148,6 |
% | % | p.p. | |
Profitability of capital | 99 | 87,3 | -11,7 |
Equity capital to total assets | 99,5 | 68,5 | -31 |
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 212.23934936523438 | 3.1738386154174805 | -209 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane